Please assess the completion status of the following clinical trial:

Trial Title: Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Pre-Electrophysiology Study Inclusion Criteria:~* Supraventricular tachycardia (SVT) compatible with atrioventricular nodal reentrant tachycardia (AVNRT), documented by ECG, TTM, Holter or event monitor~Pre-Electrophysiology Study Exclusion Criteria:~* History of sustained (≥30 seconds) of ventricular tachycardia~* Atrial tachycardia or other arrhythmia that could be confused with AVNRT~* Reversible cause of SVT~* History of previous AVNRT ablation~* Therapy with amiodarone within last 90 days~* Unstable angina/myocardial infarction/open heart surgery in past 60 days~* New York Heart Association (NYHA) Classification III or IV currently or within the past 90 days~* Implantable cardiac rhythm device~* Atrioventricular block (first degree (PR interval ≥ 220ms), second degree, or third degree) or left bundle branch block~* Stroke or transient ischemic attack within the past 180 days~* Life expectancy less than 12 months~* Female known to be pregnant~* Unable/unwilling to give informed consent~* Unable/unwilling to comply with follow-up visits and study requirements~* Less than 18 years of age~* Active systemic infection~* Cryoglobulinemia~* Other conditions where the manipulation of the catheter would be unsafe (for example, intracardiac mural thrombus)~* Participating in a concurrent clinical study that may confound the results of this study~Post-Electrophysiology Study Inclusion Criteria:~* Subject must have one electrophysiology study documented inducible sustained (greater than or equal to 15 seconds) supraventricular tachycardia that is classified as AVNRT.~Post-Electrophysiology Study Exclusion Criteria:~* Presence of a second inducible arrhythmia that could be confused with AVNRT during follow-up or will likely result in ablation within the next 6 months~* Presence of inducible sustained ventricular tachycardia or fibrillation~* Presence of an accessory pathway~* Presence of abnormal conduction or refractoriness parameters of the atrioventricular conduction system.~* Indication for a pacemaker, defibrillator or cardiac resynchronization therapy (CRT)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cryoablation (Type: EXPERIMENTAL): Subjects diagnosed with atrioventricular nodal reentrant tachycardia and treated by cryoablation with Freezor Xtra.

Based on this trial design, predict the completion outcome and termination type (if applicable).